Sponsor Pipeline

Jian Lin Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07686744 Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma Renal Cell Carcinoma Not Yet Recruiting
Disease Areas
Kidney Cancer (1)
Get alerts when Jian Lin's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free